Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05749068 · ClinicalTrials.gov registry record · NA
Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine
A NA study, sponsored by Envivo Bio.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05749068 is a NA study that has completed, run by Envivo Bio. The registered enrollment target is 10 participants.
The verdict
NCT05749068, a NA study, has completed, sponsored by Envivo Bio.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Evaluation of the CapScan intestinal collection device in characterizing the metabolism of sulfasalazine in the digestive tracts of healthy volunteers.
Interventions
- DEVICE CapScan intestinal sampling device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2022-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05749068
The ClinicalTrials.gov registry entry for NCT05749068 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Envivo Bio, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CapScan intestinal sampling device is the first listed.
NCT05749068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05749068 about?
NCT05749068 is a clinical study titled "Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine". Evaluation of the CapScan intestinal collection device in characterizing the metabolism of sulfasalazine in the digestive tracts of healthy volunteers.
What is the current status of trial NCT05749068?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-09-01. Estimated completion is 2022-10-30.
What interventions are being tested in trial NCT05749068?
The interventions under investigation include: CapScan intestinal sampling device (DEVICE).
Who is sponsoring clinical trial NCT05749068?
This trial is sponsored by Envivo Bio, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.